Literature DB >> 19667287

Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique.

Liang Jin1, Jian Li, Roger L Nation, Joseph A Nicolazzo.   

Abstract

A sensitive and reliable liquid chromatographic method was developed and validated for the determination of colistin concentrations in mouse brain homogenate. With a mobile phase consisting of acetonitrile-tetrahydrofuran-water (50:25:25 [vol/vol]) at a flow rate of 1 ml/min, a linear correlation between peak area and colistin concentration was observed over the concentration range of 93.8 to 3,000 ng/g in brain tissue (R2 > 0.994). Intra- and interday coefficients of variation were 5.1 to 8.3% and 5.8 to 8.5%, respectively, and the recovery ranged from 85% to 94%. This assay was then utilized to determine the amount of colistin that permeated the blood-brain barrier over a 2-h period following bolus intravenous administration of colistin sulfate to mice. After a single dose of 5 mg/kg of body weight to mice, brain homogenate concentrations of colistin were very low, relative to plasma colistin concentrations, suggesting that colistin permeability across the healthy blood-brain barrier is negligible during this experimental period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667287      PMCID: PMC2764184          DOI: 10.1128/AAC.00485-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier.

Authors:  Y Zhang; W M Pardridge
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

2.  Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  M E Jiménez-Mejías; C Pichardo-Guerrero; F J Márquez-Rivas; D Martín-Lozano; T Prados; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-03-19       Impact factor: 3.267

3.  A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography.

Authors:  J Li; R W Milne; R L Nation; J D Turnidge; K Coulthard; D W Johnson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-25

4.  Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  Binding of antibiotics to tissue homogenates.

Authors:  C M Kunin
Journal:  J Infect Dis       Date:  1970-01       Impact factor: 5.226

6.  Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy.

Authors:  J Koch-Weser; V W Sidel; E B Federman; P Kanarek; D C Finer; A E Eaton
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

7.  Lamotrigine analysis in blood and brain by high-performance liquid chromatography.

Authors:  M M Castel-Branco; A M Almeida; A C Falcão; T A Macedo; M M Caramona; F G Lopez
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-05-05

Review 8.  The clinical use of colistin in patients with cystic fibrosis.

Authors:  P Beringer
Journal:  Curr Opin Pulm Med       Date:  2001-11       Impact factor: 3.155

9.  High-performance liquid chromatographic method for the determination of colistin in serum.

Authors:  P P Le Brun; A I de Graaf; A A Vinks
Journal:  Ther Drug Monit       Date:  2000-10       Impact factor: 3.681

10.  Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS.

Authors:  Britt Jansson; Matti Karvanen; Otto Cars; Diamantis Plachouras; Lena E Friberg
Journal:  J Pharm Biomed Anal       Date:  2008-12-24       Impact factor: 3.935

View more
  9 in total

1.  Computational prediction of CNS drug exposure based on a novel in vivo dataset.

Authors:  Christel A S Bergström; Susan A Charman; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2012-06-29       Impact factor: 4.200

Review 2.  Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.

Authors:  Rick Dersch; E Robinson; L Beume; S Rauer; W-D Niesen
Journal:  Neurol Sci       Date:  2014-12-11       Impact factor: 3.307

3.  Melatonin attenuates colistin-induced nephrotoxicity in rats.

Authors:  Jumana M Yousef; Gong Chen; Prue A Hill; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo.

Authors:  Liang Jin; Roger L Nation; Jian Li; Joseph A Nicolazzo
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

5.  Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice.

Authors:  Liang Jin; Jian Li; Roger L Nation; Joseph A Nicolazzo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 6.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice.

Authors:  Liang Jin; Jian Li; Roger L Nation; Joseph A Nicolazzo
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

8.  Colistimethate Acidic Hydrolysis Revisited: Arrhenius Equation Modeling Using UPLC-QToF MS.

Authors:  Ioanna Dagla; Anthony Tsarbopoulos; Evagelos Gikas
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

9.  Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Ozioma F Nwabor; Pawarisa Terbtothakun; Supayang P Voravuthikunchai; Sarunyou Chusri
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.